Logo image of VEZ.DE

VEGANZ GROUP AG (VEZ.DE) Stock Fundamental Analysis

FRA:VEZ - Deutsche Boerse Ag - DE000A3E5ED2 - Common Stock - Currency: EUR

16.65  +1.45 (+9.54%)

Fundamental Rating

1

Overall VEZ gets a fundamental rating of 1 out of 10. We evaluated VEZ against 56 industry peers in the Food Products industry. Both the profitability and financial health of VEZ have multiple concerns. VEZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

VEZ had negative earnings in the past year.
In the past year VEZ has reported a negative cash flow from operations.
VEZ had negative earnings in each of the past 5 years.
In the past 5 years VEZ always reported negative operating cash flow.
VEZ.DE Yearly Net Income VS EBIT VS OCF VS FCFVEZ.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

With a Return On Assets value of -52.75%, VEZ is not doing good in the industry: 91.07% of the companies in the same industry are doing better.
With a Return On Equity value of -1022.63%, VEZ is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -52.75%
ROE -1022.63%
ROIC N/A
ROA(3y)-32.13%
ROA(5y)-27.32%
ROE(3y)-88.1%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VEZ.DE Yearly ROA, ROE, ROICVEZ.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -500 -1K -1.5K -2K

1.3 Margins

The Gross Margin of VEZ (40.20%) is comparable to the rest of the industry.
VEZ's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for VEZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5YN/A
VEZ.DE Yearly Profit, Operating, Gross MarginsVEZ.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 -40

0

2. Health

2.1 Basic Checks

VEZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VEZ has more shares outstanding
Compared to 1 year ago, VEZ has a worse debt to assets ratio.
VEZ.DE Yearly Shares OutstandingVEZ.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
VEZ.DE Yearly Total Debt VS Total AssetsVEZ.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

VEZ has an Altman-Z score of -0.16. This is a bad value and indicates that VEZ is not financially healthy and even has some risk of bankruptcy.
VEZ has a worse Altman-Z score (-0.16) than 83.93% of its industry peers.
A Debt/Equity ratio of 9.19 is on the high side and indicates that VEZ has dependencies on debt financing.
With a Debt to Equity ratio value of 9.19, VEZ is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 9.19
Debt/FCF N/A
Altman-Z -0.16
ROIC/WACCN/A
WACC6.68%
VEZ.DE Yearly LT Debt VS Equity VS FCFVEZ.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

VEZ has a Current Ratio of 0.99. This is a bad value and indicates that VEZ is not financially healthy enough and could expect problems in meeting its short term obligations.
VEZ has a worse Current ratio (0.99) than 75.00% of its industry peers.
A Quick Ratio of 0.75 indicates that VEZ may have some problems paying its short term obligations.
VEZ has a worse Quick ratio (0.75) than 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.75
VEZ.DE Yearly Current Assets VS Current LiabilitesVEZ.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M

3

3. Growth

3.1 Past

VEZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.41%.
The Revenue for VEZ has decreased by -32.10% in the past year. This is quite bad
Measured over the past years, VEZ shows a very negative growth in Revenue. The Revenue has been decreasing by -15.03% on average per year.
EPS 1Y (TTM)-26.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.9%
Revenue 1Y (TTM)-32.1%
Revenue growth 3Y-15.03%
Revenue growth 5YN/A
Sales Q2Q%-22.67%

3.2 Future

Based on estimates for the next years, VEZ will show a small growth in Earnings Per Share. The EPS will grow by 1.00% on average per year.
Based on estimates for the next years, VEZ will show a very strong growth in Revenue. The Revenue will grow by 38.04% on average per year.
EPS Next Y-30.94%
EPS Next 2Y-9.27%
EPS Next 3Y1%
EPS Next 5YN/A
Revenue Next Year-50.73%
Revenue Next 2Y-18.91%
Revenue Next 3Y4.46%
Revenue Next 5Y38.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VEZ.DE Yearly Revenue VS EstimatesVEZ.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
VEZ.DE Yearly EPS VS EstimatesVEZ.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -2 -4 -6 -8 -10

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VEZ. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VEZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VEZ.DE Price Earnings VS Forward Price EarningsVEZ.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VEZ.DE Per share dataVEZ.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.27%
EPS Next 3Y1%

0

5. Dividend

5.1 Amount

No dividends for VEZ!.
Industry RankSector Rank
Dividend Yield N/A

VEGANZ GROUP AG

FRA:VEZ (6/6/2025, 7:00:00 PM)

16.65

+1.45 (+9.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-13 2024-11-13
Earnings (Next)N/A N/A
Inst Owners13.65%
Inst Owner ChangeN/A
Ins Owners18.6%
Ins Owner ChangeN/A
Market Cap20.81M
Analysts80
Price Target17.7 (6.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.46%
PT rev (3m)9.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 19.71
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.63
EYN/A
EPS(NY)-7.74
Fwd EYN/A
FCF(TTM)-4.49
FCFYN/A
OCF(TTM)-3.09
OCFYN/A
SpS11.49
BVpS0.84
TBVpS-7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.75%
ROE -1022.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.2%
FCFM N/A
ROA(3y)-32.13%
ROA(5y)-27.32%
ROE(3y)-88.1%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5YN/A
F-Score2
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 9.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 68.99%
Cap/Sales 12.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.75
Altman-Z -0.16
F-Score2
WACC6.68%
ROIC/WACCN/A
Cap/Depr(3y)94.61%
Cap/Depr(5y)64.85%
Cap/Sales(3y)7.19%
Cap/Sales(5y)4.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.9%
EPS Next Y-30.94%
EPS Next 2Y-9.27%
EPS Next 3Y1%
EPS Next 5YN/A
Revenue 1Y (TTM)-32.1%
Revenue growth 3Y-15.03%
Revenue growth 5YN/A
Sales Q2Q%-22.67%
Revenue Next Year-50.73%
Revenue Next 2Y-18.91%
Revenue Next 3Y4.46%
Revenue Next 5Y38.04%
EBIT growth 1Y13.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.36%
EBIT Next 3Y21.47%
EBIT Next 5Y26.95%
FCF growth 1Y73.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.99%
OCF growth 3YN/A
OCF growth 5YN/A